sales costs equaled 160.8 million baht and the sales costs for 2016 equaled 154.7 million baht for percentages of 88.89 and 90.47, respectively. As a result, the Company made a gross profit of 20.1

' securities trading accounts. They traded UKEM shares in concealment on a continual basis and matched orders within the group to mislead the general public in UKEM share trading values and volumes, causing

inflated the share price and matched the trading orders within the group in concealment to mislead the public into believing that TPC shares were actively traded or TPC share price was changed.  They also

trading. This resulted in high impact on RICH shares trading values and volumes while a number of trading orders were matched within the said group.  {B} {C} and {D} aided or abetted the aforesaid actions

the trading volume of such shares on a large scale.  In addition, several trading orders were matched within the same group, causing the PYLON trading to be inconsistent with the normal market condition

incurred with total revenue from medical treatment for the 2nd quarterof Year 2019, equaled to 85.9% comparing to the 2nd quarter of Year 2018, equaled to 73.3%. The main reasons of the increasing in cost of

of the revenues can be explained as follows: 1. REVENUES FROM SALES OF MANUFACTURING AND TRADING GOODS In the second quarter of 2020, the revenues from sales was THB 698.97 million, equaled to 99.70

compared to total revenue from medical treatment in the 1st quarter of Year 2020 equaled to 79.0%, and in the 1st quarter of Year 2019 equaled to 80.2%. A decrease of nearly 1.2% in the cost of medical

quarter of Year 2018, equaled to 63.3% comparing to the 1st quarter of Year 2017, equaled to 66.9%. It was in the declining period. The Company focused on controlling costs including the higher in total

%. Costs of hospital operations incurred with total revenues from medical treatment for the Year 2018, equaled to 68.8% comparing to the Year 2017, equaled to 71.7%. Causing from the increasing of overtime